tirzepatide in mash Drug treatment of from none to (too) many options? Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

Tirzepatide is a novel dual agonist that targets both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor ( 2 Literature search strategy This narrative review aimed to synthesize current mechanistic and clinical evidence regarding tirzepatide in obesity-related OSAS

doi: 10.1186/1742-2094-9-276 97 KappeC.PatroneC.HolstJ

Cheap versions often have much lower actual berberine content than advertised

High treatment costs have fueled a growing grey market of compounded semaglutide products, raising concerns among regulators over quality, consistency, and patient safety

Secondly, Ironman 70.3 Warsaw, I was at a tipping point

ChemBioChem 20 , 28342840 (2019)